Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts. more
Time Frame | ISPC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -14.37% | -0.94% | -2.6% |
1-Month Return | -33.96% | -5.08% | -1.08% |
3-Month Return | -49.64% | -10.62% | 3.45% |
6-Month Return | -60.89% | -6.18% | 8.57% |
1-Year Return | -72% | 1.98% | 24.3% |
3-Year Return | -98.79% | -0.93% | 25.58% |
5-Year Return | -98.04% | 33.84% | 84.07% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 4.30M | 8.18M | 11.14M | 10.40M | 9.93M | [{"date":"2019-12-31","value":38.6,"profit":true},{"date":"2020-12-31","value":73.5,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.42,"profit":true},{"date":"2023-12-31","value":89.16,"profit":true}] |
Cost of Revenue | 2.13M | 3.59M | 5.25M | 4.76M | 4.82M | [{"date":"2019-12-31","value":40.54,"profit":true},{"date":"2020-12-31","value":68.31,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":90.63,"profit":true},{"date":"2023-12-31","value":91.83,"profit":true}] |
Gross Profit | 2.17M | 4.60M | 5.89M | 5.65M | 5.11M | [{"date":"2019-12-31","value":36.87,"profit":true},{"date":"2020-12-31","value":78.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.91,"profit":true},{"date":"2023-12-31","value":86.78,"profit":true}] |
Gross Margin | 50.49% | 56.19% | 52.86% | 54.27% | 51.45% | [{"date":"2019-12-31","value":89.87,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.08,"profit":true},{"date":"2022-12-31","value":96.58,"profit":true},{"date":"2023-12-31","value":91.56,"profit":true}] |
Operating Expenses | 6.05M | 7.01M | 11.81M | 15.83M | 16.28M | [{"date":"2019-12-31","value":37.17,"profit":true},{"date":"2020-12-31","value":43.04,"profit":true},{"date":"2021-12-31","value":72.56,"profit":true},{"date":"2022-12-31","value":97.26,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (3.88M) | (2.41M) | (5.93M) | (10.19M) | (11.17M) | [{"date":"2019-12-31","value":-388008900,"profit":false},{"date":"2020-12-31","value":-240638000,"profit":false},{"date":"2021-12-31","value":-592524600,"profit":false},{"date":"2022-12-31","value":-1018608200,"profit":false},{"date":"2023-12-31","value":-1116934900,"profit":false}] |
Total Non-Operating Income/Expense | (2.73M) | (4.34M) | (5.13M) | (129.46K) | 178.83K | [{"date":"2019-12-31","value":-1525.38,"profit":false},{"date":"2020-12-31","value":-2428.09,"profit":false},{"date":"2021-12-31","value":-2867.51,"profit":false},{"date":"2022-12-31","value":-72.39,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (4.88M) | (4.65M) | (8.96M) | (10.25M) | (11.10M) | [{"date":"2019-12-31","value":-488405000,"profit":false},{"date":"2020-12-31","value":-465208400,"profit":false},{"date":"2021-12-31","value":-896181500,"profit":false},{"date":"2022-12-31","value":-1024592200,"profit":false},{"date":"2023-12-31","value":-1109948800,"profit":false}] |
Income Taxes | (157.00K) | 2.11M | 1.05M | (1.21M) | 3.00 | [{"date":"2019-12-31","value":-7.45,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.04,"profit":true},{"date":"2022-12-31","value":-57.21,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (4.73M) | (6.76M) | (10.02M) | (9.04M) | (11.10M) | [{"date":"2019-12-31","value":-472705000,"profit":false},{"date":"2020-12-31","value":-675853300,"profit":false},{"date":"2021-12-31","value":-1001596800,"profit":false},{"date":"2022-12-31","value":-904072300,"profit":false},{"date":"2023-12-31","value":-1109949100,"profit":false}] |
Income From Continuous Operations | (4.73M) | (4.65M) | (8.96M) | (10.25M) | (11.10M) | [{"date":"2019-12-31","value":-472705000,"profit":false},{"date":"2020-12-31","value":-465208400,"profit":false},{"date":"2021-12-31","value":-896181500,"profit":false},{"date":"2022-12-31","value":-1024592200,"profit":false},{"date":"2023-12-31","value":-1109948800,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (4.73M) | (6.76M) | (10.02M) | (9.04M) | (11.10M) | [{"date":"2019-12-31","value":-472705000,"profit":false},{"date":"2020-12-31","value":-675853300,"profit":false},{"date":"2021-12-31","value":-1001596800,"profit":false},{"date":"2022-12-31","value":-904072300,"profit":false},{"date":"2023-12-31","value":-1109948800,"profit":false}] |
EPS (Diluted) | (5.44) | (3.25) | (0.95) | (1.16) | (1.21) | [{"date":"2019-12-31","value":-543.98,"profit":false},{"date":"2020-12-31","value":-324.97,"profit":false},{"date":"2021-12-31","value":-95,"profit":false},{"date":"2022-12-31","value":-116,"profit":false},{"date":"2023-12-31","value":-121,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ISPC | |
---|---|
Cash Ratio | 0.28 |
Current Ratio | 0.74 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ISPC | |
---|---|
ROA (LTM) | -44.26% |
ROE (LTM) | -109.34% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ISPC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ISPC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.28 |
P/B | 0.61 |
Price/FCF | NM |
EV/R | 0.22 |
EV/Ebitda | 0.43 |
iSpecimen Inc (ISPC) share price today is $2.8
Yes, Indians can buy shares of iSpecimen Inc (ISPC) on Vested. To buy iSpecimen Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ISPC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of iSpecimen Inc (ISPC) via the Vested app. You can start investing in iSpecimen Inc (ISPC) with a minimum investment of $1.
You can invest in shares of iSpecimen Inc (ISPC) via Vested in three simple steps:
The 52-week high price of iSpecimen Inc (ISPC) is $12.2. The 52-week low price of iSpecimen Inc (ISPC) is $2.75.
The price-to-earnings (P/E) ratio of iSpecimen Inc (ISPC) is
The price-to-book (P/B) ratio of iSpecimen Inc (ISPC) is 0.61
The dividend yield of iSpecimen Inc (ISPC) is 0.00%
The market capitalization of iSpecimen Inc (ISPC) is $2.89M
The stock symbol (or ticker) of iSpecimen Inc is ISPC